We are live on ! Find out more
ATOS icon

Atossa Therapeutics
ATOS

45 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,117% more call options, than puts

Call options by funds: $779K | Put options by funds: $64K

25% more capital invested

Capital invested by funds: $9.49M → $11.9M (+$2.36M)

0.08% less ownership

Funds ownership: 0.94% → 0.86% (-0.08%)

12% less funds holding

Funds holding: 51 → 45 (-6)

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
17
Closed
8
Calls
$779K
Puts
$64K
Net Calls
+$715K
Net Calls Change
-$78K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$67.9K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.52K
3
EMG
ETF Managers Group
New Jersey
+$8.07K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.8K
5
TRCT
Tower Research Capital (TRC)
New York
+$5.12K

Top Sellers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$484K
2
BlackRock
BlackRock
New York
-$191K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$105K
4
SM
Sabby Management
Florida
-$103K
5
Millennium Management
Millennium Management
New York
-$74.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
– +$11 +1 New
1 2
3